IMPROVING OUTCOME IN SUBARACHNOID HEMORRHAGE WITH NADROPARINE - ISCHEMIA

Academic Medical Centre Amsterdam0 个研究点目标入组 100 人开始时间: 2021年6月8日最近更新: 2021年8月17日

适应症

试验速览

暂无简介。

•SAH confirmed by CT or lumbar puncture with the causative aneurysm confirmed by CT-A and/or DSA
•Coiling of the causative aneurysm within 72 hours of initial SAH
•Informed consent within 24 hours after coiling
•Adult age (=18 years)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 60
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 40

•Stent-assisted coiling
•Contra-indications for LMWH: History of heparin-induced thrombocytopenia, Active bleeding, Known hemorrhagic diathesis due to coagulation disorders (with the exception of dis-seminated intravascular coagulation), Severe hypertension: uncontrolled hypertension with a MAP > 135mmHg, History of hypertensive or diabetic retinopathy, Active infectious endocarditis, Severe renal impairment (creatinine clearance <30 mL / min)
•No proficiency of Dutch or English language
•No informed consent

发起方

Academic Medical Centre Amsterdam